Results 81 to 90 of about 29,090 (255)

Ultrasonographic characterization of the nails in patients with psoriasis and onychomycosis

The Egyptian Journal of Radiology and Nuclear Medicine, 2015
Objective: The study aimed at assessment of ultrasound (US) in diagnosing nail psoriasis and onychomycosis. Methods: One hundred subjects were included: the psoriatic patients group (n = 25), the onychomycosis patients group (n = 25) and the control ...
Shaymaa Muhammad Ally Essayed, Mohammad Ahmad al-Shatouri, Yasser Salem Nasr Allah, Mona Ahmad Atwa   +3 more
doaj   +1 more source

Utility of MALDI‐ToF MS for Recognition and Antifungal Susceptibility of Nannizzia, an Underestimated Group of Dermatophytes

Mycoses, Volume 68, Issue 9, September 2025.
ABSTRACT Background Geophilic Nannizzia dermatophytes are increasingly implicated in stubborn skin, hair, and nail infections, yet MALDI‐TOF MS evaluations and antifungal‐susceptibility data have focused almost exclusively on N. gypsea. Biochemical profiles and MICs cut‐offs are limited. Objectives To benchmark two commercial MALDI‐TOF MS libraries and
Chao Tang, Xue Kong, Jasmijn Jansen, Katharina Vossgroene, Thi‐Lam‐An Vu, Boris Oberheitmann, Marlou Tehupeiory‐Kooreman, Shaoqin Zhou, Xin Zhou, Clement Kin‐ming Tsui, Weida Liu, Yingqian Kang, Sarah A. Ahmed, Sybren de Hoog   +13 more
wiley   +1 more source

Which oral antifungal is best for toenail onychomycosis? [PDF]

, 2007
Terbinafine, 250 mg taken daily for 12 weeks, is the best regimen for toenail onychomycosis due to better clinical and mycologic cure rates, tolerability, and cost effectiveness (strength of recommendation [SOR]: A, meta-analyses)
Hinojosa, Jose R., Hitchcock, Kristin
core  

Intra‐Operative Onychoscopy of Subungual Epidermoid Inclusions

The Journal of Dermatology, Volume 52, Issue 8, Page 1314-1316, August 2025.
ABSTRACT Subungual epidermoid inclusions (SEI) are small epithelial inclusions, sometimes solid but mostly with central keratinization of the onycholemmal type without a granular layer. Exceptionally, they become large enough to produce symptoms such as pain or swelling of the nail bed, resulting in subungual keratosis, onycholysis, or a dystrophic ...
Grigorios Theodosiou, Peter C. Schalock, Åke Svensson   +2 more
wiley   +1 more source

Onychomycosis in Ceará (Northeast Brazil): epidemiological and laboratory aspects

Memorias do Instituto Oswaldo Cruz, 2005
Knowledge of epidemiological and mycological characteristics of onychomycosis has been noted by many authors as being an important tool for control of these fungal infections.
RSN Brilhante, RA Cordeiro, DJA Medrano, MFG Rocha, AJ Monteiro, CSP Cavalcante, TEF Meireles, JJC Sidrim   +7 more
doaj   +1 more source

Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis [PDF]

, 2017
Patient adherence is a key consideration in the choice of a topical regimen for the treatment of onychomycosis. The objective of this study was to investigate patient-reported outcomes (treatment utilisation, adherence and satisfaction) in onychomycosis ...
Allevato, Baran, Carroll, Drake, Effendy, Feldman, Fischer, Friedman-Birnbaum, Gupta, Hay, Kinney, Lackner, Lahfa, Lauharanta, Mensing, Milobratović, Piraccini, Polak, Reich, Reinel, Sigurgeirsson, Szepietowski, Tan, Tietz, Turner, Vrijens, Wolf, Zaghloul, Zaug, Zhou   +29 more
core   +1 more source

Causes of Monodactylous Onycholysis in a Diverse Patient Population

International Journal of Dermatology, Volume 64, Issue 10, Page 1879-1880, October 2025.
Lea Tordjman, Ryan R. Scheinkman, Brian W. Morrison   +2 more
wiley   +1 more source

Dermatological Disease in the Older Age Group: A Cross-sectional Study in Aged Care Facilities [PDF]

, 2015
Background: Older people living in aged care facilities face multiple potential barriers to accessing dermatological care including physical and/or cognitive disability. This group is therefore at risk for undiagnosed and untreated dermatological disease
Deo, M, Jarrett, P, Kerse, N, Vandal, AC
core   +1 more source

Efinaconazole in the treatment of onychomycosis

Infection and Drug Resistance, 2015
Efinaconazole 10% topical solution is a new triazole recently approved for the treatment of onychomycosis. It inhibits fungal lanosterol 14α-demethylase in the ergosterol biosynthesis pathway, has potent antifungal activity against dermatophytes, as well as activity against Candida spp.
Shari R. Lipner, Richard K. Scher
openaire   +4 more sources

Global onychomycosis management and the challenges of antifungal stewardship

Journal of Dermatological Treatment
Purpose Onychomycosis, in contrast to other routine superficial dermatophyte infections, is difficult to treat and poor outcomes are not unusual. Few guidelines for onychomycosis management have been published, and these vary considerably from region to ...
Aditya K. Gupta, Elizabeth A. Cooper, Eckart Haneke, Shari R. Lipner, Ditte Marie L. Saunte, Chander Grover, Avner Shemer, Bianca M. Piraccini, Antonella Tosti, Roderick J. Hay   +9 more
doaj   +1 more source